Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

Presentations Access:

clear all | select all

Presentation Access:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123
From Chemistry to the Clinic, Part 1: The Academic/Foundation/Industry Interface (Educational Session)
Doing a biopharma start-up from academics 
Laurence H. Hurley, D.Sc., Ph.D.
Univ. of Arizona, Tucson, AZ
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
From Chemistry to the Clinic, Part 1: The Academic/Foundation/Industry Interface (Educational Session)
The evolving role of foundations in translating promising academic discoveries into breakthrough therapeutics 
Louis J. DeGennaro, Ph.D.
The Leukemia and Lymphoma Society, White Plains, NY
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
New Targets and Novel Drugs for microRNAs and the Epigenetics Machinery (Educational Session)
Novel epigenetic and microRNA drugs in cancer therapy
Manel Esteller, M.D., Ph.D.
Inst. d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
New Targets and Novel Drugs for microRNAs and the Epigenetics Machinery (Educational Session)
Recent developments of two NCI epigenetic drugs: Zebularine and 3-deazaneplanocin
Victor E. Marquez, Ph.D.
National Cancer Institute-Frederick, Frederick, MD
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
New Targets and Novel Drugs for microRNAs and the Epigenetics Machinery (Educational Session)
Sirtuins as therapeutic targets in cancer
Antonio Bedalov, M.D., Ph.D.
Fred Hutchinson Cancer Research Center, Seattle, WA
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
New Targets and Novel Drugs for microRNAs and the Epigenetics Machinery (Educational Session)
microRNA processing and target interactions
Dr. John J. Rossi
Beckman Research Institute, Duarte, CA
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
Nutrition, Obesity, and Cancer (Educational Session)
Obesity, diabetes, and risk of prostate cancer: Results from cancer prevention trials
Scott M. Lippman, M.D.
UT M. D. Anderson Cancer Center, Houston, TX
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
Nutrition, Obesity, and Cancer (Educational Session)
Chronic Inflammation Is a Link between Obesity, Cancer, and Nutrition
Bharat B. Aggarwal, Ph.D.
UT M. D. Anderson Cancer Center, Houston, TX
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
Nutrition, Obesity, and Cancer (Educational Session)
From soup to nuts: Evaluating bioactive food components in breast cancer prevention trials
Karen A. Johnson, M.D., Ph.D.
National Cancer Institute, Bethesda, MD
from AACR 101st Annual Meeting 2010 on April 17, 2010 8:00 AM-10:00 AM
Cancer Stem Cells and Treatment Resistance (Educational Session)
An evolving concept of cancer stem cells in tumor biology
Jeremy N. Rich, M.D.
The Cleveland Clinic, Cleveland, OH
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Cancer Stem Cells and Treatment Resistance (Educational Session)
Strategies for targeting breast cancer stem cells and treatment resistance 
Piyush Gupta, B.S.
Broad Inst. of MIT and Harvard, Cambridge, MA 
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
From Chemistry to the Clinic, Part 2: Pharmacokinetics in Cancer Drug Discovery and Development (Educational Session)
Pharmacokinetics in drug discovery
Michael Michaelides, Ph.D.
Abbott Laboratories, Abbott Park, IL
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
From Chemistry to the Clinic, Part 2: Pharmacokinetics in Cancer Drug Discovery and Development (Educational Session)
Pharmacokinetic and pharmacodynamic considerations in translational development
Andrew P. Krivoshik, M.D., Ph.D.
Abbott Laboratories, Abbott Park, IL
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
From Chemistry to the Clinic, Part 2: Pharmacokinetics in Cancer Drug Discovery and Development (Educational Session)
Pharmacokinetics in the clinical development of new anticancer agents: Where the rubber hits the road
Anthony W. Tolcher, M.D.
South Texas Accelerated Research Therapeutics, San Antonio, TX
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
From Chemistry to the Clinic, Part 2: Pharmacokinetics in Cancer Drug Discovery and Development (Educational Session)
Regulatory perspective of the role of pharmacokinetics in drug discovery and development
Dr. Julie Bullock
Food and Drug Administration, Silver Spring, MD
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
MicroRNAs and Their Binding in Cancer Risk and Development (Educational Session)
miRNA polymorphisms and cancer risk
Joanne B. Weidhaas, M.D., Ph.D.
Yale Univ. School of Medicine, New Haven, CT
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
MicroRNAs and Their Binding in Cancer Risk and Development (Educational Session)
Oncogenic miRNAs in cancer and development
Andrea Ventura, M.D., Ph.D.
Memorial Sloan-Kettering Institute, New York, NY
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
MicroRNAs and Their Binding in Cancer Risk and Development (Educational Session)
Functional dissection of a polycistronic miRNA oncogene in lymphomagenesis
Dr. Virginie Olive
University of California, Berkeley, CA
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
MicroRNAs and Their Binding in Cancer Risk and Development (Educational Session)
The other side of posttranscriptional regulation of gene expression in cancer: Altered visibility of transcripts to microRNAs and RNA binding proteins via alternative cleavage and polyadenylation
Dr. Joel R. Neilson
Baylor College of Medicine, Houston, TX
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Site-Specific Metastasis (Educational Session)
Mechanisms of site-specific metastasis to bone
Theresa A. Guise, M.D.
University of Virginia, Charlottesville, VA
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Site-Specific Metastasis (Educational Session)
Signaling pathways regulating lung metastasis
Carrie W. Rinker-Schaeffer, Ph.D.
University of Chicago, Chicago, IL
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Site-Specific Metastasis (Educational Session)
The tumor microenvironment in different stages of the hepatic metastasis process
Fernando Vidal-Vanaclocha, M.D., Ph.D.
Basque Country University School of Medicine, Bizkaia, Spain
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Site-Specific Metastasis (Educational Session)
Brain metastasis: A unique microenvironment and a sanctuary from chemotherapy
Patricia S. Steeg, Ph.D.
National Cancer Institute, Bethesda, MD
from AACR 101st Annual Meeting 2010 on April 17, 2010 10:15 AM-12:15 PM
Cancer Microenvironment: Roles of Bone Marrow-derived Cells (Educational Session)
Roles of macrophages in cancer invasion and metastasis
Dr. Jeffrey W. Pollard
Albert Einstein College of Medicine, Bronx, NY
from AACR 101st Annual Meeting 2010 on April 17, 2010 1:00 PM-3:00 PM
Cancer Microenvironment: Roles of Bone Marrow-derived Cells (Educational Session)
Roles of bone marrow-derived cells in colon cancer metastasis
Makoto Mark Taketo, M.D., Ph.D.
Kyoto University Graduate School of Medicine, Kyoto, Japan
from AACR 101st Annual Meeting 2010 on April 17, 2010 1:00 PM-3:00 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123